Pipeline · Reproductive health

Fertility Support.Pre-Clinical / Designed

Mitochondrial and oxidative-stress axis for oocyte and sperm quality. Pre-conception 90-day protocol with AMH and DNA-fragmentation as primary endpoints. Bi-gendered design.

Status: Pre-Clinical / Designed
Therapeutic area: Reproductive health
Key: 90-day window · Bi-gendered

The mechanism we're betting on.

Mitochondrial and oxidative-stress axis for oocyte and sperm quality. Pre-conception 90-day protocol with AMH and DNA-fragmentation as primary endpoints. Bi-gendered design. The full mechanism map — including compound list, dose escalation, pre-specified biomarker thresholds, and the cross-walk modifiers used when re-fitting blends from related indications — is part of the gated methodology pack.Gated

What the rest of the world is doing.

Numbers below are surfaced by Atlas Bio's ClinicalTrials.gov and PubMed RWE pipelines, run against the Fertility Support indication. Counts are industry-wide trials registered on ClinicalTrials.gov, not Atlas Bio studies. Methodology →

RWE refreshed 2026-05-12
Phase I (B1/B2)
130
trials
Phase II (B3)
200
trials
Phase III (B4)
200
trials
Phase IV (B5)
200
trials
Recent published clinical evidence

Locked before readout.

Predictions for this study are SHA-256 locked before any readout. Pre-registration covers target engagement, primary endpoint, secondary endpoints, and the falsification criterion. The hash, prediction wording, and timestamp are available to verified clinicians and indication researchers on request.Gated

Same stack, every indication.

Want the full Fertility Support protocol?

The abstract above is open. Compound lists, dose escalations, SHA-256-locked prediction documents, agent-network reasoning chains, and trial design specifics are available to verified clinicians, indication researchers, and sponsors under MNDA. Contact management to begin the access request.

Contact management →